Does Losartan reduce the severity of COVID-19 in hypertensive patients?

BACKGROUND: One of the global problems is to control the coronavirus epidemic, and the role of different medicines is still unknown to policymakers. This study was conducted to evaluate the effects of losartan on the mortality rate of COVID-19 in hypertensive patients. METHODS: The research sample o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirjalili, Mohammadreza, Soodejani, Moslem Taheri, Raadabadi, Mehdi, Dehghani, Ali, Salemi, Fateme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933856/
https://www.ncbi.nlm.nih.gov/pubmed/35305551
http://dx.doi.org/10.1186/s12872-022-02548-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933856/
https://www.ncbi.nlm.nih.gov/pubmed/35305551
http://dx.doi.org/10.1186/s12872-022-02548-2

Ejemplares similares